BioSpace News Archive

Business

Ultragenyx Reports First Quarter 2022 Financial Results and Corporate Update

Ultragenyx Pharmaceutical Inc. reported its financial results for the quarter ended March 31, 2022 and reaffirmed its financial guidance for the year.

May 5, 2022
·
12 min read
Business

Progyny, Inc. Announces First Quarter 2022 Results

Progyny, Inc. today announced its financial results for the three-month period ended March 31, 2022 (“the first quarter of 2022”) as compared to the three-month period ended March 31, 2021 (“the first quarter of 2021” or “the prior year period”).

May 5, 2022
·
22 min read
Business

RxSight, Inc. Reports First Quarter 2022 Financial Results

– RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, reported financial results for the three months ended March 31, 2022.

May 5, 2022
·
10 min read
Business

Calyxt Reports First Quarter 2022 Financial Results

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced financial results for its first quarter ended March 31, 2022.

May 5, 2022
·
31 min read
Biotech Bay

Arcellx Announces Participation at the BofA Securities 2022 Healthcare Conference

Arcellx, Inc. announced that management will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022, at 5:00 p.m. E.T.

May 5, 2022
·
2 min read
Business

ViewRay Announces First Quarter 2022 Results

ViewRay, Inc. announced financial results for the first quarter ended March 31, 2022.

May 5, 2022
·
7 min read
Business

Oncolytics Biotech® Reports First Quarter 2022 Financial Results and Recent Operational Highlights

Oncolytics Biotech® Inc. announced recent operational highlights and financial results for the first quarter ended March 31, 2022.

May 5, 2022
·
16 min read
Business

Curis Reports First Quarter 2022 Financial Results and Business Update

Curis, Inc. reported its financial results for the first quarter ended March 31, 2022 and provided business updates.

May 5, 2022
·
17 min read
Business

Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today provided a corporate update and announced preliminary and unaudited financial results for the first quarter ended March 31, 2022.

May 5, 2022
·
8 min read
Business

Ardelyx Reports First Quarter 2022 Financial Results and Recent Business Highlights

Ardelyx, Inc. provided a business update and reported financial results for the first quarter ended March 31, 2022.

May 5, 2022
·
11 min read